FDA Evaluating Study That Found Increased Death Risk From Paclitaxel Arterial Devices
SILVER SPRING, Md. — The Food and Drug Administration on Jan. 17 said it is evaluating a recent review and meta-analysis showing an increased risk of death among patients treated with...To view the full article, register now.
Already a subscriber? Click here to view full article